Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2 signaling pathway.

Liu, Aiqun; Jiang, Baohong; Song, Cailu; Zhong, Qizhi; Mo, Yufan; Yang, Ruiqin; Chen, Ciyu; Peng, Cheng; Peng, Fu; Tang, Hailin.

Afiliação

Liu A; Department of Neurology School of Clinical Medicine the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China.
Jiang B; Department of Pharmacy, the First Affiliated Hospital, Hengyang Medical School University of South China Hengyang China.
Song C; State Key Laboratory of Oncology in South China Sun Yat-sen University Cancer Center Guangzhou China.
Zhong Q; Department of Neurology School of Clinical Medicine the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China.
Mo Y; Department of Neurology School of Clinical Medicine the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China.
Yang R; Department of Neurology School of Clinical Medicine the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China.
Chen C; Department of Neurology School of Clinical Medicine the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China.
Peng C; State Key Laboratory of Southwestern Chinese Medicine Resources Chengdu University of Traditional Chinese Medicine Chengdu China.
Peng F; West China School of Pharmacy Sichuan University Chengdu China.
Tang H; State Key Laboratory of Oncology in South China Sun Yat-sen University Cancer Center Guangzhou China.